SCHEMBL6542872

SCHEMBL6542872

CSC(=O)O[C@]1(C(=O)O)CC(=O)O[C@@H]1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11692139 0.71 CYP1A2 (0.32)
SCHEMBL11832451 0.71 CYP1A2 (0.32)
SCHEMBL11785262 0.65 GRM8 (0.30)
SCHEMBL4653448 0.65 GRM8 (0.30)
SCHEMBL8133012 0.65 GRM8 (0.30)
SCHEMBL6541949 0.65 GRM8 (0.30)
SCHEMBL8307214 0.60 LMNA (0.33)
SCHEMBL25293536 0.52 HTT (0.43)
SCHEMBL25247790 0.52 HTT (0.43)
SCHEMBL18597084 0.51 CYP19A1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6703515-B2 4,5-DICARBOXY DERIVATIVES OF BUTYROLACTONES DEPARTMENT OF SCIENCE AND TECHNOLOGY, TECHNOLOGY BHAVAN (IN) 2004-03-09 US disclosed
US-20030088110-A1 Novel chiral derivatives of hibiscus acid bearing lactone ring moiety, process for preparing the same and a convenient method for the large-scale isolation of hibiscus acid CARESTREAM HEALTH, INC. 2003-05-08 US disclosed